Tumor Necrosis Factor-alpha Levels as a Predictor of Clinical Neoadjuvant Chemotherapy Response in a Luminal-type Locally Advance Breast Cancer in Surabaya, Indonesia

• Үндсэн зохиолчид: Hanindyo Riezky Beksono (Зохиогч), Iskandar Ali (Зохиогч), Marjono Dwi Wibowo (Зохиогч), Bara Kharisma (Зохиогч), Rizki Amalia (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Wolters Kluwer - Medknow Publications, 2024-03-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Introduction: The prevalence of locally advanced breast cancer (LABC) increases annually, especially in the luminal type. Chemotherapy is one of the treatments used to manage breast cancer. Biomarkers are needed to predict the outcome of chemotherapy, one of which is tumor necrosis factor-alpha (TNF...